Madison, WI, United States of America

Hermann Bultmann

This inventor holds 4 USPTO granted patents. Top assignee: Wisconsin Alumni Research Foundation. Active years: 2008-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hermann Bultmann. Retrieved from https://idiyas.com/inventor/hermann-bultmann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2008-2014

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Hermann Bultmann: Innovator in Antiviral Peptide Research

Introduction

Hermann Bultmann is a notable inventor based in Madison, WI (US), recognized for his contributions to the field of antiviral research. With a total of 4 patents, Bultmann has made significant strides in developing pharmacologically active antiviral peptides.

Latest Patents

Bultmann's latest patents focus on the creation of peptides that possess antiviral properties. These antiviral peptides include membrane transiting peptides, along with their active fragments and derivatives. The peptides demonstrate efficacy against a wide range of viruses, both enveloped and nonenveloped. They are designed for use in pharmaceutical compositions aimed at preventing and treating viral infections.

Career Highlights

Bultmann is affiliated with the Wisconsin Alumni Research Foundation, where he continues to advance his research in antiviral therapies. His work has garnered attention for its potential impact on public health, particularly in combating viral infections.

Collaborations

Bultmann collaborates with Curtis R Brandt, contributing to the innovative research environment at the Wisconsin Alumni Research Foundation.

Conclusion

Hermann Bultmann's work in antiviral peptide research exemplifies the importance of innovation in addressing viral infections. His patents reflect a commitment to advancing medical science and improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…